← All Paragon 28, INC filings

Paragon 28, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

FNA
Paragon 28, INC
10-Q: Paragon 28 Reports 18% Revenue Growth in Q3 2024, Despite Increased Losses
Paragon 28, a medical device company focused on foot and ankle orthopedics, announced an 18% increase in revenue for the third quarter of 2024, but also reported increased net losses and identified material weaknesses in internal controls.
FNA
Paragon 28, INC
10-Q: Paragon 28 Reports 18% Revenue Growth in Second Quarter Despite Increased Operating Expenses
Paragon 28, a medical device company focused on foot and ankle orthopedics, announced an 18% increase in revenue for the second quarter of 2024, although operating expenses also rose.
FNA
Paragon 28, INC
10-Q/A: Paragon 28 Restates Q1 2024 Financials Due to Inventory Errors
Paragon 28 has restated its first quarter 2024 financial statements due to material accounting errors related to inventory valuation.
FNA
Paragon 28, INC
10-Q: Paragon 28 Reports 17% Revenue Growth in First Quarter 2024, Driven by New Product Launches and Sales Expansion
Paragon 28, a medical device company focused on foot and ankle orthopedics, announced a 17% increase in net revenue for the first quarter of 2024, driven by new product launches and sales force expansion.